Atossa Genetics: Potential Breakthrough in Breast Cancer?
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
- Latest
- Trending
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
Sharp HealthCare is leading the way in bringing Apple's Vision Pro VR headset into healthcare. The high-resolution screens and advanced ...
The Federal Reserve is facing pressure to cut interest rates, but evidence suggests that its patience in delaying rate cuts ...
The global Assisted Reproductive Technology market is projected to grow by $8.23 billion by 2027, driven by rising infertility rates ...
The use of robotic-assisted surgery and surgical navigation techniques does not increase the risk of joint infection in total hip ...
Microsoft has resolved the strange bug in Windows 11 that caused chaos with multi-monitor setups, shuffling desktop icons around. The ...
Discover how sleep technology has evolved to include smart mattresses, wearable sleep trackers, and light therapy devices for better sleep. ...
Dr. Leonel Hunt joins Ocutrx Medical Advisory Board to guide innovation in digital loupe technology, enhancing precision in spine surgery ...
Discover the impact of AI on healthcare - from improved diagnosis to personalized treatments and streamlined admin tasks. Ethical considerations ...
Discover the game-changing role of Artificial Intelligence (AI) in the field of Radiology, enhancing patient care at Regional Medical Imaging ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.